The global life sciences BPO market size is expected to reach USD 827.5 billion by 2030, registering a CAGR of 9.3% over the forecast years, according to a new report by Grand View Research, Inc. The rising costs of drug development; pre-clinical and clinical trials; and post-marketing surveillance; a rise in the patent cliff; a growing product pipeline; and regulatory constraints are...